enGene Therapeutics Inc. (ENGN) Current Reports & Earnings Releases
Upcoming
- 2026-09-10 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-16 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-15 | 8-K | Results of Operations, Item 2.05, Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-10 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-09 | 8-K | Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Material Agreement, Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2026-01-21 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-21 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-12-22 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-02 | 8-K | Officer / Director Changes | SEC |
| 2025-09-30 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-09-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-03 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-08 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-10 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-06-09 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2025-06-04 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-12-20 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-12-19 | 8-K | Material Agreement, Results of Operations, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-10-25 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-21 | 8-K | Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-26 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-05 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-07-24 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2024-05-15 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-14 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.